Core Team

The Imago team is composed of experienced professionals who are veterans of venerated companies such as Genzyme, Genentech, Amgen, Pharmacia, and Searle. This team has worked together for ten years pioneering the small company corporate model of distributed operations working out of offices and labs from San Francisco to Somerset, England.

The team is led by Hugh Young Rienhoff, Jr., a physician with 25 years of experience in the field of biotechnology. The operational team provides broad oversight of clinical trials, studies, quality and chemical manufacturing. Imago’s operational model facilitates the team’s management of CMC activities and clinical studies in Europe, Asia and North America in multiple therapeutic areas, notably hematology and oncology. Imago has established many collaborations with clinical investigators and scientists to continuously enhance the scientific foundation of our clinical programs.

THE PROMISE OF IMAGO

Imago is developing pioneering medicines for the treatment of myeloproliferative diseases.